A clearer roadmap for TH-1902 pleaseWould it not be better for all involved if TH just gave investors a better roadmap for where TH-1902 has been and is going? Obviously, where it is going in its trials is not yet fully known but many of the options are. So, why not just lay out for investors some of those options rather than keep everything so confused. What would be the harm in that and why don't most biotechs do that? Investors know this is an uncertain situation and can handle it. Adding to that uncertainty by not sharing what can reasonably be expected seems like less than ideal.